155 related articles for article (PubMed ID: 22959823)
1. 1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma.
Singhal SS; Figarola J; Singhal J; Leake K; Nagaprashantha L; Lincoln C; Gabriel Gugiu B; Horne D; Jove R; Awasthi S; Rahbar S
Biochem Pharmacol; 2012 Dec; 84(11):1419-27. PubMed ID: 22959823
[TBL] [Abstract][Full Text] [Related]
2. Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression.
Singhal SS; Figarola J; Singhal J; Nagaprashantha L; Berz D; Rahbar S; Awasthi S
Biochem Pharmacol; 2013 Dec; 86(12):1664-72. PubMed ID: 24099794
[TBL] [Abstract][Full Text] [Related]
3. Small‑molecule COH-SR4 inhibits adipocyte differentiation via AMPK activation.
Figarola JL; Rahbar S
Int J Mol Med; 2013 May; 31(5):1166-76. PubMed ID: 23525347
[TBL] [Abstract][Full Text] [Related]
4. Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosis.
Figarola JL; Weng Y; Lincoln C; Horne D; Rahbar S
Invest New Drugs; 2012 Aug; 30(4):1413-25. PubMed ID: 21728022
[TBL] [Abstract][Full Text] [Related]
5. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo anti-tumor activity of CoQ0 against melanoma cells: inhibition of metastasis and induction of cell-cycle arrest and apoptosis through modulation of Wnt/β-catenin signaling pathways.
Hseu YC; Thiyagarajan V; Tsou HT; Lin KY; Chen HJ; Lin CM; Liao JW; Yang HL
Oncotarget; 2016 Apr; 7(16):22409-26. PubMed ID: 26968952
[TBL] [Abstract][Full Text] [Related]
7. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
8. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.
Madhunapantula SV; Desai D; Sharma A; Huh SJ; Amin S; Robertson GP
Mol Cancer Ther; 2008 May; 7(5):1297-308. PubMed ID: 18483317
[TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells.
Pisano M; Pagnan G; Dettori MA; Cossu S; Caffa I; Sassu I; Emionite L; Fabbri D; Cilli M; Pastorino F; Palmieri G; Delogu G; Ponzoni M; Rozzo C
Mol Cancer; 2010 Jun; 9():137. PubMed ID: 20525240
[TBL] [Abstract][Full Text] [Related]
10. Dehydroleucodine inhibits tumor growth in a preclinical melanoma model by inducing cell cycle arrest, senescence and apoptosis.
Costantino VV; Lobos-Gonzalez L; Ibañez J; Fernandez D; Cuello-Carrión FD; Valenzuela MA; Barbieri MA; Semino SN; Jahn GA; Quest AF; Lopez LA
Cancer Lett; 2016 Mar; 372(1):10-23. PubMed ID: 26718258
[TBL] [Abstract][Full Text] [Related]
11. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
[TBL] [Abstract][Full Text] [Related]
12. Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis.
Saleem M; Maddodi N; Abu Zaid M; Khan N; bin Hafeez B; Asim M; Suh Y; Yun JM; Setaluri V; Mukhtar H
Clin Cancer Res; 2008 Apr; 14(7):2119-27. PubMed ID: 18381953
[TBL] [Abstract][Full Text] [Related]
13. Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation.
Kaluzki I; Hrgovic I; Hailemariam-Jahn T; Doll M; Kleemann J; Valesky EM; Kippenberger S; Kaufmann R; Zoeller N; Meissner M
Tumour Biol; 2016 Oct; 37(10):13627-13635. PubMed ID: 27468725
[TBL] [Abstract][Full Text] [Related]
14. A novel derivative of quinazoline, WYK431 induces G2/M phase arrest and apoptosis in human gastric cancer BGC823 cells through the PI3K/Akt pathway.
Wang TE; Wang YK; Jin J; Xu BL; Chen XG
Int J Oncol; 2014 Aug; 45(2):771-81. PubMed ID: 24859921
[TBL] [Abstract][Full Text] [Related]
15. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma.
Singhal J; Nagaprashantha LD; Vatsyayan R; Ashutosh ; Awasthi S; Singhal SS
Cancer Prev Res (Phila); 2012 Mar; 5(3):473-83. PubMed ID: 22174364
[TBL] [Abstract][Full Text] [Related]
16. DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.
Qiao F; Zuo D; Shen X; Qi H; Wang H; Zhang W; Wu Y
Cancer Chemother Pharmacol; 2012 Aug; 70(2):259-70. PubMed ID: 22752214
[TBL] [Abstract][Full Text] [Related]
17. Glaucocalyxin A induces cell cycle arrest and apoptosis via inhibiting NF-κB/p65 signaling pathway in melanoma cells.
Chen J; Zhang W; Pan C; Fan J; Zhong X; Tang S
Life Sci; 2021 Apr; 271():119185. PubMed ID: 33577846
[TBL] [Abstract][Full Text] [Related]
18. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
[TBL] [Abstract][Full Text] [Related]
20. A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton.
Zhang J; Zhou J; Ren X; Diao Y; Li H; Jiang H; Ding K; Pei D
Invest New Drugs; 2012 Apr; 30(2):490-507. PubMed ID: 21080210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
